Dr. Ebubechukwu Njemanze, MD

Dr. Njemanze practices at Emory Hillandale Hospital in Lithonia, Georgia, part of Emory University.

Dr. Njemanze's NPI, 1144774712, was assigned on August 11, 2016. Dr. Njemanze holds Georgia license 97422.

Dr. Njemanze's primary practice is Emory Hillandale Hospital, at 2801 Dekalb Medical Parkway, Lithonia, GA 30058 in De Kalb County. The practice phone is (404) 501-8040.

Dr. Njemanze's primary practice is Emory Hillandale Hospital in Lithonia, Georgia, part of Emory University. Dr. Njemanze is also affiliated with University of New Mexico Hospital. The medical group on file is Emory Healthcare. Dmand AI also links Dr. Njemanze to 1 more hospital, 8 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Njemanze practices, 7 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Njemanze's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Njemanze is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Njemanze's licenses on file in 2 states: Georgia and New Mexico.

CMS data shows 405 Medicare services from Dr. Njemanze across 5 procedure codes in 2024, for 384 Medicare patients. Medicare paid $41,797 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 384 Medicare patients who saw Dr. Njemanze in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Njemanze's median patient age at 69, with 57% women.

In 2024, Dr. Njemanze wrote 88 Medicare Part D claims for 59 patients. 89% of them were for generic drugs. They cover 70 drugs, with $112,430 in total drug cost. In 2022, CMS named 6,782 claims across 127 drugs.

CMS Open Payments shows 4 general payments to Dr. Njemanze from 4 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $105.